StockData
VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30

VitaNova Life Sciences Corp

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$4.50+0.50 (+12.50%)

Close on Oct 19, 2026

Market cap
$37.52M
P/E (TTM)
–
Dividend yield
–

VitaNova Life Sciences Corp revenue by segment

By business segment

RevenueQ1 27Q4 26Q3 26Q2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24% of revenueYoY
Healthy Food Products [Member]$234.58K–––––––––––72.9%–
Dietary Supplement Segment [Member]$87.00K$721.98K$705.34K$420.63K$99.67K$1.95M$301.32K$288.28K––––27.1%-12.7%
Consulting Service Segment [Member]––$4.29K$6.49K$4.23K$0$7.00K$3.84K$0–––––
Healthcare Segment [Member]––––$99.67K$1.95M$301.32K$288.28K$108.48K–––––
Other [Member]––––$4.23K–––––––––
Operating incomeQ1 27Q4 26Q3 26Q2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24YoY
Dietary Supplement Segment [Member]-$29.10K-$412.83K$298.37K$232.13K$50.40K$1.15M$165.34K$121.90K––––-157.7%
Healthy Food Products [Member]-$93.07K––––––––––––
Consulting Service Segment [Member]––-$251.63K-$132.96K-$82.84K-$62.89K-$56.46K-$59.30K-$92.07K––––
Healthcare Segment [Member]––––$50.40K$1.15M$165.34K$121.90K$46.65K––––
Other [Member]––––-$82.84K––––––––

By product or service

RevenueQ1 27Q4 26Q3 26Q2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24% of revenueYoY
Sale Of Food Products [Member]$234.58K–––––––––––72.9%–
Dietary Supplement Products [Member]$87.00K–––$99.67K–––––––27.1%-12.7%
Sale Of Healthcare Products [Member]––$705.34K$420.63K$99.67K$1.95M$301.32K$288.28K$108.48K–––––
Consulting Service Income [Member]–$0$4.29K$6.49K$4.23K$0$7.00K$3.84K$0–––––

By region

RevenueQ1 27Q4 26Q3 26Q2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24% of revenueYoY
Hong Kong SAR China–$146.33K$199.25K$0$0$766.46K$105.00K$92.30K$108.48K$81.75K$0$0––
Unites States Of America [Member]–$1.64M$510.38K$427.12K$103.90K$887.40K$196.32K$120.62K$0$51.75K$26.10K$0––
China–$0$0$0–$299.52K$7.00K$79.20K–$411.10K$0$0––

From the segment and revenue-disaggregation notes of VitaNova Life Sciences's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.